Northern Trust’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Buy |
258,369
+8,244
| +3% | +$82.2K | ﹤0.01% | 2844 |
|
|
2025
Q1 | $1.49M | Sell |
250,125
-9,612
| -4% | -$57.4K | ﹤0.01% | 3077 |
|
|
2024
Q4 | $1.99M | Buy |
259,737
+7,881
| +3% | +$60.5K | ﹤0.01% | 3025 |
|
|
2024
Q3 | $2.57M | Buy |
251,856
+10,301
| +4% | +$105K | ﹤0.01% | 2846 |
|
|
2024
Q2 | $3.58M | Sell |
241,555
-8,247
| -3% | -$122K | ﹤0.01% | 2580 |
|
|
2024
Q1 | $3.41M | Sell |
249,802
-7,048
| -3% | -$96.1K | ﹤0.01% | 2703 |
|
|
2023
Q4 | $2.81M | Sell |
256,850
-20,385
| -7% | -$223K | ﹤0.01% | 2810 |
|
|
2023
Q3 | $3.04M | Buy |
277,235
+10,397
| +4% | +$114K | ﹤0.01% | 2711 |
|
|
2023
Q2 | $3.53M | Buy |
266,838
+14,819
| +6% | +$196K | ﹤0.01% | 2690 |
|
|
2023
Q1 | $3.43M | Sell |
252,019
-1,668
| -0.7% | -$22.7K | ﹤0.01% | 2678 |
|
|
2022
Q4 | $4.95M | Buy |
253,687
+11,874
| +5% | +$232K | ﹤0.01% | 2494 |
|
|
2022
Q3 | $4.61M | Buy |
241,813
+8,528
| +4% | +$162K | ﹤0.01% | 2546 |
|
|
2022
Q2 | $4.81M | Buy |
233,285
+35,401
| +18% | +$729K | ﹤0.01% | 2543 |
|
|
2022
Q1 | $6.37M | Buy |
197,884
+12,250
| +7% | +$394K | ﹤0.01% | 2438 |
|
|
2021
Q4 | $8.64M | Buy |
185,634
+9,188
| +5% | +$428K | ﹤0.01% | 2337 |
|
|
2021
Q3 | $4.76M | Buy |
176,446
+3,843
| +2% | +$104K | ﹤0.01% | 2764 |
|
|
2021
Q2 | $4.43M | Sell |
172,603
-20,106
| -10% | -$516K | ﹤0.01% | 2911 |
|
|
2021
Q1 | $6.59M | Buy |
192,709
+60,766
| +46% | +$2.08M | ﹤0.01% | 2566 |
|
|
2020
Q4 | $4.46M | Buy |
131,943
+4,279
| +3% | +$145K | ﹤0.01% | 2747 |
|
|
2020
Q3 | $3.15M | Buy |
+127,664
| New | +$3.15M | ﹤0.01% | 2811 |
|